Study of Cognitive-Behavioral Therapy and Digital Tools to Prevent Suicide Risk in Women with Eating Disorders Aged 18 to 65

What this Trial Is About

Researchers are evaluating whether adding a digital intervention to standard cognitive-behavioral therapy CBT can better prevent suicide risk and reduce symptoms of eating disorders in women aged 18 to 65 years who have recently experienced suicidal thoughts or attempts. This randomized clinical trial aims to compare outcomes between a group receiving only standard group therapy and another group receiving group therapy combined with digital tools. The study is sponsored by Universitat Autonoma de Barcelona and focuses on improving clinical outcomes and safety for patients with eating disorders and suicide risk. Participants will be assigned to one of two groups one receiving eight structured group CBT sessions based on Christopher Fairburns program, and the other receiving the same CBT sessions plus digital therapy. The digital therapy includes a mobile application featuring a digital safety plan with warning signs, coping strategies, and emergency contacts, which is activated by real-time risk assessments through 2 to 4 random daily questions. The treatment period lasts eight weeks. During the study, participants will be assessed at baseline, at the end of treatment week 8, and again at six and twelve months to measure changes in eating disorder symptoms, suicide risk, depression, and anxiety using standardized scales such as the Eating Attitudes Test-26 EAT-26, Bulimic Investigatory Test Edinburgh BITE, Columbia Suicide Severity Rating Scale C-SSRS, Patient Health Questionnaire-9 PHQ-9, and Generalized Anxiety Disorder-7 GAD-7. These assessments help monitor clinical progress and safety throughout the trial period.

Cognitive-Behavioral and Digital Therapy for Suicide Risk in Eating Disorders